Expert Ratings For Pacira BioSciences
Expert Ratings For Pacira BioSciences
Pacira Biosciences的專家評級
Pacira BioSciences (NASDAQ:PCRX) has been analyzed by 8 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在過去的三個月中，有8位分析師對Pacira BioSciences（納斯達克股票代碼：PCRX）進行了分析，揭示了從看漲到看跌的不同觀點。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表彙總了他們最近的評級，闡明瞭過去30天內情緒的變化，並將其與前幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $41.88, with a high estimate of $57.00 and a low estimate of $25.00. Highlighting a 8.72% decrease, the current average has fallen from the previous average price target of $45.88.
分析師對12個月目標股價的評估提供了更多見解，顯示平均目標價爲41.88美元，最高估計爲57.00美元，低估值爲25.00美元。當前的平均價格已從之前的45.88美元的平均目標股價有所下降，這凸顯了8.72％的跌幅。
Decoding Analyst Ratings: A Detailed Look
解碼分析師評級：詳細介紹
An in-depth analysis of recent analyst...
對分析師近期行...
登入免費觀看全文
登入/註冊